Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 26.10.2021.

Graft-versus-host disease
Human anatomy
Biotechnology
Transplant rejection
Heart
Biology

Healthcare

@matthewherper shared
On Oct 25, 2021
RT @GZuckerman: Ugur Sahin and Stephane Bancel are responsible for modern science's greatest achievement. This is the story of how they did it--a @WSJ adaptation of A Shot to Save the World, out on Tuesday. https://t.co/xwrxQ1IKoM
Open
The Unlikely Outsiders Who Won the Race for a Covid-19 Vaccine

The Unlikely Outsiders Who Won the Race for a Covid-19 Vaccine

Uğur Şahin and Stéphane Bancel were long underestimated by investors and scientists. But when Covid-19 threatened the globe, these two unknowns had a solution.

@Biotechnology shared
On Oct 21, 2021
Global Roundup: Newly-Launched AION Forms Startup in Israel https://t.co/5RRbQkk5lr https://t.co/NSkyZb8TAD
Open
Global Roundup: Newly-Launched AION Forms Startup in Israel

Global Roundup: Newly-Launched AION Forms Startup in Israel

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.

@NatureBiotech shared
On Oct 22, 2021
Offaly good – A pig kidney has been successfully transplanted into a human for the first time #NBTintheNews via @TheEconomist https://t.co/g0y7uhXvVp
Open
@BIODeutschland shared
On Oct 20, 2021
RT @Roche: 📢 Roche reports strong growth in the first nine months – outlook for 2021 raised 👉Read the full media release here: https://t.co/nj1LoASAlG $ROG $RHHBY #RocheFinancialResults https://t.co/IzPjraiUng
Open
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised

Group sales up 8%1 at constant exchange rates (CER); 6% in Swiss francs Pharmaceuticals Division sales grow 5% in the third quarter and are now in line with the prior year for the …

@Biotechnology shared
On Oct 21, 2021
Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab https://t.co/lx60nY1aY1 https://t.co/5yjBDgIpt3
Open
Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab

Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab

The license and collaboration agreement allows Janssen to use F-star’s proprietary technology in the research, development and commercialization of novel bispecific antibodies.

@HealthcareLdr shared
On Oct 24, 2021
Scientists temporarily attached a pig kidney to a human body, and the organ worked. https://t.co/kI1Dc4znyc https://t.co/slMVOPrMgp
Open
Pig-to-Human Transplants Come a Step Closer With New Test

Pig-to-Human Transplants Come a Step Closer With New Test

Scientists have temporarily attached a pig’s kidney to a human body and watched it begin to work.

@BIODeutschland shared
On Oct 26, 2021
Leadership change and even more momentum: Biotech pioneer Neovii under new management https://t.co/JEj3EkjVUd
Open
Leadership change and even more momentum: Biotech pioneer Neovii under new management

Leadership change and even more momentum: Biotech pioneer Neovii under new management

Leadership change and even more momentum: Biotech pioneer Neovii under new management - NEOVII

@Biotechnology shared
On Oct 20, 2021
Life Sciences Industry in California Defies Pandemic-Driven Employment Downturn https://t.co/Iox4U8yCFG https://t.co/W1NiXXWwMl
Open
Life Sciences Industry in California Defies Pandemic-Driven Employment Downturn

Life Sciences Industry in California Defies Pandemic-Driven Employment Downturn

Although California is already a well-known hotbed for science and technology, the pandemic still precipitated a surge of activity in the life sciences industry.